J9051 HCPCS Level II code: Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg
J9051 is the HCPCS code for “Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9051Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg
Short description: Inj, bortezomib (maia)
HCPCS · United States
Medicare details
The indicators CMS publishes with J9051 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care
- BETOS category
- Chemotherapy
- Added
- Oct 1, 2023
Where J9051 sits
- 1J codesDrugs administered other than orally
- 2Active code J9051Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9051 mean?
J9051 is the HCPCS code for “Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9051?
CMS lists J9051’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9051
All J codesJ9045Injection, carboplatin, 50 mgJ9046Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mgJ9047Injection, carfilzomib, 1 mgJ9048Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mgJ9049Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mgJ9050Injection, carmustine, 100 mgJ9052Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mgJ9053Injection, belantamab mafodotin-blmf, 0.1 mgJ9054Injection, bortezomib (boruzu), 0.1 mgJ9055Injection, cetuximab, 10 mgJ9056Injection, bendamustine hydrochloride (vivimusta), 1 mgJ9057Injection, copanlisib, 1 mg